Evidence map›Paper›PMID 32978693›Full record

ArticleMolecular diversity2021

Synthesis, characterization, antibacterial evaluation, 2D-QSAR modeling and molecular docking studies for benzocaine derivatives.

Israa Taha, Eman M Keshk, Abdel-Galil M Khalil, Ahmed Fekri

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Israa TahaChemistry Department, Faculty of Science, Mansoura University, 25 El Gomhouria St, Mansoura, Dakahlia Governorate, 35516, Egypt.ORCID http://orcid.org/0000-0002-7244-532X
Eman M KeshkChemistry Department, Faculty of Science, Mansoura University, 25 El Gomhouria St, Mansoura, Dakahlia Governorate, 35516, Egypt.
Abdel-Galil M KhalilChemistry Department, Faculty of Science, Mansoura University, 25 El Gomhouria St, Mansoura, Dakahlia Governorate, 35516, Egypt.
Ahmed FekriChemistry Department, Faculty of Science, Mansoura University, 25 El Gomhouria St, Mansoura, Dakahlia Governorate, 35516, Egypt. fekria@mans.edu.eg.ORCID http://orcid.org/0000-0001-9733-1161
Mansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Possible application of incorporating a well-known drug (benzocaine) with cyanoacetamide function to get a powerful synthon ethyl 4-cyanoacetamido benzoate. This synthetic intermediate was used as a precursor for the synthesis of triazine, pyridone, thiazolidinone, thiazole and thiophene scaffolds containing the benzocaine core. Facile coupling, Michael addition, condensation and nucleophilic attack reactions were used to synthesize our targets. The structural features of the synthesized scaffolds were characterized using IR,

Indexed as

Molecular Docking SimulationQuantitative Structure-Activity RelationshipAnti-Bacterial AgentsBacterial ProteinsBenzocaineInhibitory Concentration 50LigandsMicrobial Sensitivity TestsPrincipal Component AnalysisStaphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsBenzocaineLigands1,2,4-TriazineAntibacterialBenzocaineMolecular operating environment (MOE)Staphylococcus aureusThiophene

Identifiers

PMID32978693
OpenAlexW3088174339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.